I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 0.9226 USD -3.8% Market Closed
Market Cap: 74.6m USD
Have any thoughts about
I-Mab?
Write Note

Wall Street
Price Targets

IMAB Price Targets Summary
I-Mab

Wall Street analysts forecast IMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMAB is 6.885 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

Lowest
Price Target
5.05 USD
447% Upside
Average
Price Target
6.885 USD
646% Upside
Highest
Price Target
8.4 USD
810% Upside
I-Mab Competitors:
Price Targets
2616
CStone Pharmaceuticals
31% Upside
EXAS
Exact Sciences Corp
37% Upside
002007
Hualan Biological Engineering Inc
26% Upside
CRVO
Diffusion Pharmaceuticals Inc
513% Upside
ALERS
Eurobio Scientific SA
19% Upside
IGMS
IGM Biosciences Inc
122% Upside
206650
EuBiologics Co Ltd
12% Upside
BBIO
BridgeBio Pharma Inc
108% Upside

Revenue
Forecast

Revenue Estimate
I-Mab

For the last 5 years the compound annual growth rate for I-Mab's revenue is -12%.

-12%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
I-Mab

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
I-Mab

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMAB's stock price target?
Price Target
6.885 USD

According to Wall Street analysts, the average 1-year price target for IMAB is 6.885 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

Back to Top